Esflorin1® can be used across a wide range of foods without compromising taste or texture, from dairy and dairy alternatives to confectionery, snacks, and savoury products. Formats include UHT milk, gummies, fresh pasta, and tea bags.
Esflorin1® supports digestive health
Support digestive health with Esflorin1® Postbiotic (Bifidobacterium longum CECT 7347), a clinically backed, versatile heat-treated microorganism that may help reduce bloating and address other consumer needs³,⁴.
Next-generation postbiotic for gut health support
Esflorin1® Postbiotic is an award-winning microbiome ingredient, developed through ADM’s advanced research capabilities to support overall digestive health.
- An inanimate version of Bifidobacterium longum CECT 7347, a strain isolated from healthy breast-fed infants
- Derived from exposure to ADM’s proprietary heat-treatment technology
- May support overall gut health, including bloating and occasional diarrhea based on clinical evidence, with a daily intake of 2.5B HT cells
- Easily incorporated into appealing food, beverage, and supplement applications
- Winner of the VitaFoods Europe Innovation Award 2025, Digestive Health; FoodBev Health Innovation Award 2024, Gut Health Gummies; Food Ingredient Europe (FIE) Health Innovation Award 2024; and Gulfood Manufacturing Industry Excellence Award 2023, Digestive Health
As more consumers understand the impact of gut health on wellbeing, postbiotics open up new ways to support digestive health.
Digestive health support
Clinical studies investigated the effects of Esflorin1® Postbiotic on digestive health and quality of life, showing:
May reduce bloating and occasional diarrhea
A probiotic study shows Esflorin1® Postbiotic may support beneficial gut microbe activity compared to baseline³,⁴.
Positive changes to the gut microbiome
Research shows Esflorin1® Postbiotic may support the activity of beneficial gut microbes when compared to baseline³.
Better quality of life
In a clinical trial, 85% of subjects reported improved quality of life after taking Esflorin1® Postbiotic⁵.
With advanced research capabilities and a portfolio of proprietary probiotic strains, ADM is making next-generation microbiome technology. A heat-treated, whole-cell microorganism, Esflorin1® Postbiotic marks a new era in gut health.
Esflorin1® Postbiotic’s non-living cells may be combined freely with vitamins, minerals, and botanicals, making them potentially beneficial for dietary supplements to support gut health, in formats ranging from capsules to powders to gummies.
Esflorin1® Postbiotic offers opportunities for specialized nutrition applications, including sports gels, electrolyte drinks, protein beverages, and nutritional snacks. ADM’s application research demonstrates versatility across a range of formats.
Clinical evidence
See how Esflorin1® Postbiotic can enhance your product development, with full application support, formulation expertise, and diverse ingredient portfolio.
Hi! We're Performing Maintenance.
ERROR CODE: 503
Here are some helpful links
Hello
Esflorin1® Postbiotic technical details and availability
Explore the technical specifications of Esflorin1® Postbiotic, including its preparation and composition, concentration, recommended daily intake, processing stability, and compliance certifications.
Preparation and composition
Concentration and intake
Processing and stability
Compliance
Esflorin1® Postbiotic resources
Explore more ADM postbiotics
Support metabolic health with BPL1®
L. gasseri CP2305 for stress, mood, and sleep support
Postbiotic solutions from ADM
This content is intended for business-to-business (B2B) informational purposes only and not directed to consumers. The information provided summarizes scientific research and should not be interpreted as evidence that any ingredient, product, claim, or statement has been approved, authorized, validated, or accepted by any regulatory authority in any jurisdiction. References to scientific studies do not establish that any claim is permitted for use in a particular jurisdiction or product category. The ingredients described in this content are not intended to diagnose, treat, cure, or prevent any disease. Ingredients, permitted uses, and claims must be reviewed under applicable local laws and regulations before use in any specific product, category, or market by companies for their finished products.
Esflorin1® is a trademark registered for Biopolis S.L. in the EU and other countries.
Sources
¹ADM OutsideVoice℠ 2024 Global Consumer Health Survey, ADM, 2024
²ADM OutsideVoice℠ Postbiotics Survey 2024 & 2025, ADM, 2025
³Srivastava et al. (2024), Gut Microbes, 16:2338322
⁴Naghibi et al. (2024), Nutrients 16:3952
⁵Cardoso et al. (2026), Allergy, 0:1–13